
Burjeel's $500m sukuk gives UAE healthcare CFOs a 7.125% debt benchmark
Burjeel Holdings priced a $500 million five-year sukuk due 2031 after orders reached $1.6 billion, giving UAE healthcare CFOs a live unsecured funding benchmark.
How Zavis verifies this coverage
Editorial standards, source rules, methodology, and review provenance are public.
Burjeel Holdings priced a $500 million five-year senior unsecured sukuk due 2031 at a 7.125% yield, after orders reached $1.6 billion.
For UAE healthcare CFOs and CEOs, the deal gives hospital groups a current market price for unsecured healthcare credit as expansion, refinancing and technology spending compete for capital. In a Business Wire release dated 25 June 2026, Burjeel Holdings said the sukuk was 3.2 times oversubscribed, with pricing tightened to a 7.000% profit rate.
Why the benchmark matters
The sukuk was issued under Burjeel Holdings' new $1.5 billion senior unsecured sukuk programme, according to the company release. Burjeel Holdings said it was the first sukuk by a MENA healthcare provider since 2018. S&P Global Ratings assigned the group a BB+ rating, and Moody's Ratings assigned Ba2.
International investors took 61% of the final allocation, according to Burjeel Holdings. The company said UK investors accounted for 34%, US offshore investors for 24%, and GCC investors for 39%. That mix matters for UAE issuers because it shows scaled private healthcare credit can attract buyers outside regional bank liquidity.
"This transaction broadens our access to global capital markets." Dr. Shamsheer Vayalil, Chairman and CEO, Burjeel Holdings
Citi, Emirates NBD Capital and First Abu Dhabi Bank acted as joint global coordinators, according to the release. Emirates NBD Capital and First Abu Dhabi Bank were also sukuk structuring agents. ADCB, ADIB, Dubai Islamic Bank, RAKBANK and Sharjah Islamic Bank were joint lead managers and bookrunners.
What finance teams should model
The number to remember is the 7.125% yield. Burjeel Holdings said it was the lowest five-year yield for a GCC-based private non-investment grade corporate issuer since 2020. Peers can use that external mark in refinancing talks, covenant planning and acquisition models, with an adjustment for scale and rating.
Burjeel Holdings later said the sukuk proceeds were used mainly to refinance existing debt. In its H1 2026 update, the group said it fully repaid an AED 1.598 billion term loan and reduced drawings under its First Abu Dhabi Bank revolving credit facility by AED 209 million. Net leverage stood at 1.8 times as of 30 June 2026, according to company reporting carried by UAE media.
- $500 million five-year senior unsecured sukuk due 2031.
- $1.6 billion peak orderbook, equal to 3.2 times cover.
- 61% allocation to international investors, including 34% from the UK and 24% from US offshore investors.
- BB+ from S&P Global Ratings and Ba2 from Moody's Ratings.
Operating read-through
Burjeel Holdings is headquartered in Abu Dhabi. The Department of Health - Abu Dhabi, Dubai Health Authority and Ministry of Health and Prevention remain the named licensing and oversight authorities for healthcare operators across Abu Dhabi, Dubai and the Northern Emirates. The sukuk does not change licensing rules; it changes the financing comparison for operators planning new capacity or refinancing bank debt.
Burjeel Holdings' network spans 94 assets across the UAE, Oman and Saudi Arabia, including 20 hospitals, 44 medical centres and physiotherapy centres, 16 pharmacies and 14 allied-service assets, according to its H1 2026 materials filed through the Abu Dhabi Securities Exchange. That scale is why the deal reaches beyond one issuer. Smaller hospital groups may pay more, but lenders will use Burjeel Holdings' transaction when assessing sector risk, cash conversion and sponsor discipline.
Burjeel Holdings linked the financing to advanced clinical care, research, medical education and AI-enabled healthcare investment in its 25 June 2026 release. CIOs and medical directors should treat that as a capital allocation signal. Debt-funded investment still has to clear Department of Health - Abu Dhabi, Dubai Health Authority and Ministry of Health and Prevention requirements on patient safety, data governance and facility approvals.
The next test is whether other UAE healthcare groups follow Burjeel Holdings into public debt markets before 2027. If they do, pricing gaps will show which operators have enough scale, margin visibility and regulator-ready growth plans to raise unsecured capital without relying only on bank facilities.
Intelligence Desk
Editorial
Contributing to UAE healthcare industry coverage
Related coverage
FAQ
What are the latest UAE healthcare regulations?
Burjeel's $500m sukuk gives UAE healthcare CFOs a 7.125% debt benchmark. Burjeel Holdings priced a $500 million five-year sukuk due 2031 after orders reached $1.6 billion, giving UAE healthcare CFOs a live unsecured funding benchmark. Read the full analysis on Zavis Healthcare Industry Insights.



